Compass Pathways
Business Services · United Kingdom · 51-200 Employees
View Company Info for Free
Overview
Headquarters
33 Broadwick Street, London, Greater Lon...Phone Number
+44 7166766461Website
www.compasspathways.comRevenue
-Stock Symbol
CMPSIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
4
1
2
2
2
1
About Compass Pathways
COMPASS Pathways plc (Nasdaq: CMPS) is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. Our focus is on improving the lives of those who are suffering with mental health challenges and who are not helped by current treatments. We are pioneering the development of a new model of psilocybin therapy, in which our proprietary formulation of synthetic psilocybin, COMP360, is administered in conjunction with psychological support.Explore more
Compass Pathways Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Compass Pathways your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Compass Pathways launches new products
Compass Pathways, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Compass Pathways
Funding: Get notified immidiatlly once Compass Pathways has new funding data
Check out if Compass Pathways is spiking on competitors!
Earning: See what the market has to say on Compass Pathways recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Compass Pathways had a recent Job posting/layoffs
Check if Compass Pathways has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Compass Pathways
Compare insights from companies similar to Compass Pathways, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Compass Pathways is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Compass Pathways is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Compass Pathways.
Compass Pathways financials insights
Gather financial insights about Compass Pathways, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2018
Series A
$35.5M
2020
Series B
$80M
Stock Offering
$128M
2023
Debt
$50M
Other Financing Round
$285M
Compass Pathways Tech Stack
A closer look at the technologies used by Compass Pathways
See more technologies
Most Recent Scoops
Person-Based
Events, Medical Research
Open Position
Open Position
Open Position
Project
Laboratory Operations, Medical Research, Clinical Operations
Compass Pathways News & Media
COMPASS Pathways plc (CMPS) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
COMPASS Pathways plc (CMPS) Morgan Stanley 24th Annual Global Healthcare Conference September 16, 2026 11:30 AM EDTCompany ParticipantsKabir Nath - CEO...Fluence Selected by Compass Pathways to Develop Post-Approval COMP360 Provider Training
New certificate program will prepare clinicians to support patients receiving COMP360 psilocybin treatment, if approved by the FDA NEW YORK, Sept. 10, 2026 /PRNewswire/ -- Fluence, a leading provider of professional education in psychedelic therapy, today announced that it has been...Compass Pathways Announces U.S. Grant Program Recipients for the Development of Post ...
Five organizations awarded grants, above the planned three, as a result of a competitive selection process with highly qualified applicants Training guidance is designed to prepare healthcare providers to deliver high-quality treatment experiences to patients receiving COMP360, if approved Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to unlocking urgently needed new treatment options in mental health care, announced today the U.S. grant program recipients to create traiCompass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing ...
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to unlocking urgently needed new treatment options in mental health care, announced today that Compass granted equity awards under the Compass Pathways plc 2026 Inducement Plan to thirty-one newly hired non-executive employees. The equity awards were granted on September 1, 2026 and consisted of options to purchase an aggregate of 280,600 shares and restricted share units or, in the case of employees in the United Kingdom
Read more news
Top Business Services Companies
See more top companies
Frequently Asked Questions Regarding Compass Pathways
Sign Up For FreeTo access detailed company insights
COMPASS Pathways plc (Nasdaq: CMPS) is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. Our focus is on improving the lives of those who are suffering with mental health challenges and who are not helped by current treatments. We are pioneering the development of a new model of psi... Read More
